Evidence map›Paper›PMID 19439650›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2009

A thyroid hormone receptor mutation that dissociates thyroid hormone regulation of gene expression in vivo.

Danielle S Machado, Amin Sabet, Leticia A Santiago, Aniket R Sidhaye, Maria I Chiamolera, Tania M Ortiga-Carvalho, Fredric E Wondisford

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 2 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 2 syntheses or guidelines pooled it, 81 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Thyroid Hormone Action by Genomic and Nongenomic Molecular Mechanisms.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  4. Article
  5. TRα2-An Untuned Second Fiddle or Fine-Tuning Thyroid Hormone Action?International journal of molecular sciences · 2022
    Review
  6. Thyroid hormone receptor phosphorylation regulates acute fasting-induced suppression of the hypothalamic-pituitary-thyroid axis.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. The actions of thyroid hormone signaling in the nucleus.Molecular and cellular endocrinology · 2017
    Review
  12. Article
  13. New insights into thyroid hormone action.Pharmacology & therapeutics · 2017
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Both estrogen receptor α and β stimulate pituitary GH gene expression.Molecular endocrinology (Baltimore, Md.) · 2014
    Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Danielle S MachadoDepartment of Pediatrics and Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Amin Sabet
Leticia A Santiago
Aniket R Sidhaye
Maria I Chiamolera
Tania M Ortiga-Carvalho
Fredric E Wondisford
Johns Hopkins Medicine · USJohns Hopkins University · USUniversidade Federal do Rio de Janeiro · BR

Funding

JHU-UMD Diabetes Research CenterP30DK079637 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI WONDISFORD, FREDRIC E. · 2013 to 2017
$9.7M
Diabetes Research and Training CenterP60DK079637 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI WONDISFORD, FREDRIC E. · 2008 to 2012
$9.1M
THYROID HORMONE ACTION IN THE PITUITARYR01DK049126 · NIDDK · UNIVERSITY OF CHICAGO · PI WONDISFORD, FREDRIC E. · 1995 to 2016
$3.8M
MOLECULAR MECHANISMS OF THYROID HORMONE RESISTANCER01DK053036 · NIDDK · UNIVERSITY OF CHICAGO · PI WONDISFORD, FREDRIC E. · 1999 to 2009
$2.7M
Negative Regulation of the Central Thyroid Axis by Thyroid HormoneF32DK077420 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI SABET, AMIN · 2008 to 2008
$57k
NIDDK NIH HHS DK077420NIDDK NIH HHS DK49126NIDDK NIH HHS DK53036NIDDK NIH HHS DK79637NIDDK NIH HHS F32 DK077420NIDDK NIH HHS P30 DK079637NIDDK NIH HHS P60 DK079637NIDDK NIH HHS R01 DK049126NIDDK NIH HHS R01 DK053036
6 · The paper itself

Abstract

Resistance to thyroid hormone (RTH) is most often due to point mutations in the beta-isoform of the thyroid hormone (TH) receptor (TR-beta). The majority of mutations involve the ligand-binding domain, where they block TH binding and receptor function on both stimulatory and inhibitory TH response elements. In contrast, a few mutations in the ligand-binding domain are reported to maintain TH binding and yet cause RTH in certain tissues. We introduced one such naturally occurring human RTH mutation (R429Q) into the germline of mice at the TR-beta locus. R429Q knock-in (KI) mice demonstrated elevated serum TH and inappropriately normal thyroid-stimulating hormone (TSH) levels, consistent with hypothalamic-pituitary RTH. In contrast, 3 hepatic genes positively regulated by TH (Dio1, Gpd1, and Thrsp) were increased in R429Q KI animals. Mice were then rendered hypothyroid, followed by graded T(3) replacement. Hypothyroid R429Q KI mice displayed elevated TSH subunit mRNA levels, and T(3) treatment failed to normally suppress these levels. T(3) treatment, however, stimulated pituitary Gh levels to a greater degree in R429Q KI than in control mice. Gsta, a hepatic gene negatively regulated by TH, was not suppressed in R429Q KI mice after T(3) treatment, but hepatic Dio1 and Thrsp mRNA levels increased in response to TH. Cardiac myosin heavy chain isoform gene expression also showed a specific defect in TH inhibition. In summary, the R429Q mutation is associated with selective impairment of TH-mediated gene repression, suggesting that the affected domain, necessary for TR homodimerization and corepressor binding, has a critical role in negative gene regulation by TH.

Indexed as

Point MutationAnimalsGene Knock-In TechniquesHumansMiceMice, TransgenicRepressor ProteinsThyroid Hormone Receptors betaThyroid Hormone Resistance SyndromeTriiodothyronineRepressor ProteinsThyroid Hormone Receptors betaTriiodothyronine

Identifiers

PMID19439650
PMCPMC2695112
OpenAlexW2082283713

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.